1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Biofrontera AG
  6. News
  7. Summary
    B8F   DE0006046113

BIOFRONTERA AG

(B8F)
  Report
Delayed Xetra  -  05/23 11:36:26 am EDT
1.085 EUR   +2.36%
05/19TRANSCRIPT : Biofrontera AG, Q1 2022 Earnings Call, May 19, 2022
CI
05/17Biofrontera AG Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/13Earnings Flash (BFRI) BIOFRONTERA Posts Q1 Revenue $9.8M, vs. Street Est of $9.83M
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

European ADRs Move Slightly Higher in Monday Trading

11/29/2021 | 11:23am EDT


© MT Newswires 2021
Stocks mentioned in the article
ChangeLast1st jan.
AKARI THERAPEUTICS, PLC 0.26% 1.13 Delayed Quote.-24.67%
ARGENX SE -0.98% 302.3 Real-time Quote.-4.12%
AUTOLUS THERAPEUTICS PLC -1.09% 2.71 Delayed Quote.-47.78%
AVADEL PHARMACEUTICALS PLC -4.17% 3.68 Delayed Quote.-54.46%
BIOFRONTERA AG 2.36% 1.085 Delayed Quote.-26.69%
BIONTECH SE 0.13% 163.22 Delayed Quote.-36.69%
CRH PLC 0.79% 37.485 Real-time Quote.-19.42%
DBV TECHNOLOGIES 6.30% 2.87 Real-time Quote.-6.18%
ENDAVA PLC -0.08% 95.9 Delayed Quote.-42.89%
IDEX BIOMETRICS ASA -1.83% 1.237 Real-time Quote.-60.85%
IDEX CORPORATION 0.01% 185.5 Delayed Quote.-21.50%
NATUZZI S.P.A. 5.32% 10.3 Delayed Quote.-35.34%
NUCANA PLC 3.33% 0.62 Delayed Quote.-73.95%
PEARSON PLC 0.00% 759.2 Delayed Quote.23.81%
RELX PLC 1.37% 2301 Delayed Quote.-4.20%
VOXELJET AG -1.53% 3.86 Delayed Quote.-34.58%
All news about BIOFRONTERA AG
05/19TRANSCRIPT : Biofrontera AG, Q1 2022 Earnings Call, May 19, 2022
CI
05/17Biofrontera AG Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/13Earnings Flash (BFRI) BIOFRONTERA Posts Q1 Revenue $9.8M, vs. Street Est of $9.83M
MT
05/02TRANSCRIPT : Biofrontera AG, 2021 Earnings Call, May 02, 2022
CI
04/30Biofrontera AG Reports Earnings Results for the Full Year Ended December 31, 2021
CI
04/30PTA-NEWS : Biofrontera AG: Biofrontera reports results for the fiscal year 2021
PU
04/29Biofrontera AG Provides Earnings Guidance for the Year 2022
CI
04/28PTA-NEWS : Biofrontera AG: Biofrontera shifts the publication of the Annual Report 2021 to..
PU
04/14PTA-NEWS : Biofrontera AG: Biofrontera announces conference call to be held on April 29, 2..
PU
04/13Top Midday Gainers
MT
More news
Financials
Sales 2022 35,7 M 38,1 M 38,1 M
Net income 2022 -1,00 M -1,07 M -1,07 M
Net Debt 2022 - - -
P/E ratio 2022 -54,3x
Yield 2022 -
Capitalization 61,5 M 65,8 M 65,8 M
Capi. / Sales 2022 1,72x
Capi. / Sales 2023 1,77x
Nbr of Employees 95
Free-Float 46,4%
Chart BIOFRONTERA AG
Duration : Period :
Biofrontera AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BIOFRONTERA AG
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Last Close Price 1,09 €
Average target price 3,50 €
Spread / Average Target 223%
EPS Revisions
Managers and Directors
Ludwig Lutter Chief Financial Officer
Wilhelm Konrad Zours Chairman-Supervisory Board
Heikki Lanckriet Member-Supervisory Board
Helge Lubenow Member-Supervisory Board
Karlheinz Schmelig Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
BIOFRONTERA AG-26.69%66
CSL LIMITED-5.35%93 536
SAMSUNG BIOLOGICS CO.,LTD.-9.30%46 268
WUXI BIOLOGICS (CAYMAN) INC.-39.17%30 229
BIOGEN INC.-16.89%29 203
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.-23.96%22 798